Lilly’s commitment came a day after tech giant Apple announced a $500 billion commitment over the next four years to its ...

Novo Nordisk and Eli Lilly (with its Zepbound) are the two reigning kings on the U.S. market these days. There will be more contenders; Viking Therapeutics, in particular, is in the later stages of ...

WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical ...

Tesla stock’s tumble has hit Musk’s wealth hard, Eli Lilly is doubling down on U.S. factories amid trade threat, and more ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...

Eli Lilly plans to open four new pharmaceutical manufacturing sites in the U.S., expanding its $50bn capital commitments ...

Eli Lilly and Company said Wednesday they plan to build new pharmaceutical manufacturing sites in the United States.

Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas. The ...

Healthcare company stocks ended lower on a rough day for biotech companies and medical providers. Molina Healthcare and Centene notched big declines the day after a House budget resolution threatened ...

At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...

Eli Lilly announces plans to build four new U.S. manufacturing facilities, enhancing domestic pharmaceutical production and creating jobs.